What is the link between the Johnson and Johnson vaccine and Guillain-Barre syndrome?

The Food and Drug Administration (“FDA”) recently added Guillain-Barre syndrome as a potential side effect to the Johnson and Johnson Covid-19 vaccine. However, it is important to note that this is a very rare side effect and the increased risk of contracting Guillain-Barre syndrome after receiving the Johnson and Johnson vaccine is incredibly low. For example, it is estimated that there have only been around one hundred cases of Guillain-Barre syndrome from the vaccine out of the thirteen million doses of the vaccine that have been administered.

Guillain-Barre syndrome occurs when the immune system attacks the nerve cells. It is most common in adults over the age of fifty. Typically, the symptoms of Guillain-Barre syndrome will appear within six weeks of getting the vaccine. The symptoms will typically appear as muscle weakness. The syndrome can be temporary or permanent. If you believe you are experiencing Guillain-Barre syndrome, you should see your doctor immediately.

There is no cost to hire an attorney to represent you in your vaccine injury claim. Please feel free to contact us to discuss your case. If we do take your case, we will never bill you and our fees will be paid out of the VICP fund. There is literally no risk to calling us and we are more than happy to speak with you and try to help you out the best we can.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn